Chargement en cours...

AICAR TREATMENT REDUCES INTERSTITIAL FIBROSIS IN AGING MICE Suppression of the Inflammatory Fibroblast

In 2030, elderly people will represent 20% of the United States population. Even now, chronic cardiac diseases, especially heart failure with preserved systolic function (HFpEF), are the most expensive DRGs for Medicare. Progressive interstitial fibrosis in the aging heart is well recognized as an i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Mol Cell Cardiol
Auteurs principaux: Cieslik, Katarzyna A., Trial, JoAnn, Entman, Mark L.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600709/
https://ncbi.nlm.nih.gov/pubmed/28826664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2017.08.003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!